The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Major Histocompatibility Complex Class I–Recognizing Receptors Are Disease Risk Genes in Rheumatoid Arthritis
Open accessAbstract
Rheumatoid arthritis (RA) is a heterogeneous syndrome of which a subset of patients develops vascular inflammation. The genetic determinants that confer risk for rheumatoid vasculitis are not known, but patients with vascular complications are known to have an expansion of CD4+CD28null T cells, a cell population potentially involved in endothelial damage. CD4+CD28null T cell clones isolated from RA patients with vasculitis were found to express killer cell immunoglobulin–like receptors (KIRs) with the stimulatory KIR2DS2 often present in the absence of opposing inhibitory receptors with related specificities. To test the hypothesis that the KIR2DS2 gene is involved in the development of vasculitis, association studies were performed. The KIR2DS2 gene was significantly enriched among patients with rheumatoid vasculitis compared with normal individuals (odds ratio 5.56, P = 0.001) and patients with RA but no vasculitis (odds ratio 7.96, P = 0.001). Also, the distribution of human histocompatibility leukocyte antigen (HLA)-C, the putative ligand for KIRs, was significantly different in patients with rheumatoid vasculitis in comparison with the control populations. These data suggest that HLA class I–recognizing receptors and HLA class I genes are genetic risk determinants that modulate the pattern of RA expression. Specifically, KIR2DS2 in conjunction with the appropriate HLA-C ligand may have a role in vascular damage by regulating CD4+CD28null T cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lanier, L. L. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.359 · Cited by 1,648
Atherosclerosis is an inflammatory disease
Ross, R. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70266-8 · Cited by 1,451
Human Diversity in Killer Cell Inhibitory Receptor Genes
Uhrberg, M., Valiante, N. M., Shum, B. P., Shilling, H. G., Lienert-Weidenbach, K., Corliss, B., Tyan, D., Lanier, L. L., & Parham, P. (1997) · Immunity · doi:10.1016/s1074-7613(00)80394-5 · Cited by 1,059
HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A
Lee, N., Llano, M., Carretero, M., Ishitani, A., Navarro, F., López-Botet, M., & Geraghty, D. E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5199 · Cited by 1,053
REGULATION OF IMMUNE RESPONSES THROUGH INHIBITORY RECEPTORS
Long, E. O. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.875 · Cited by 939
Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells
Lanier, L. L., Corliss, B. C., Wu, J., Leong, C., & Phillips, J. H. (1998) · Nature · doi:10.1038/35642 · Cited by 904
Colonna, M., & Samaridis, J. (1995) · Science · doi:10.1126/science.7716543 · Cited by 736
Borrego, F., Ulbrecht, M., Weiss, E. H., Coligan, J. E., & Brooks, A. G. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.5.813 · Cited by 727
Wagtmann, N., Biassoni, R., Cantoni, C., Verdiani, S., Malnati, M. S., Vitale, M., Bottino, C., Moretta, L., Moretta, A., & Long, E. O. (1995) · Immunity · doi:10.1016/1074-7613(95)90025-x · Cited by 578
Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes.
Liuzzo, G., Goronzy, J. J., Yang, H., Kopecky, S. L., Holmes, D. R., Frye, R. L., & Weyand, C. M. (2000) · Circulation · doi:10.1161/01.cir.101.25.2883 · Cited by 552
Self-citationSchmidt, D., Goronzy, J. J., & Weyand, C. M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118638 · Cited by 482
Self-citationNew susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study
Cornélis, F., Fauré, S., Martinez, M., Prud’homme, J.-F., Fritz, P., Dib, C., Alves, H., Barrera, P., de Vries, N., Balsa, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10746 · Cited by 472
Colonna, M., Borsellino, G., Falco, M., Ferrara, G. B., & Strominger, J. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.12000 · Cited by 460
Moretta, A., Sivori, S., Vitale, M., Pende, D., Morelli, L., Augugliaro, R., Bottino, C., & Moretta, L. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.3.875 · Cited by 447
Winter, C. C., Gumperz, J. E., Parham, P., Long, E. O., & Wagtmann, N. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.2.571 · Cited by 422
Perturbation of the T-cell repertoire in patients with unstable angina.
Liuzzo, G., Kopecky, S. L., Frye, R. L., Fallon, W. M. O., Maseri, A., Goronzy, J. J., & Weyand, C. M. (1999) · Circulation · doi:10.1161/01.cir.100.21.2135 · Cited by 398 · cited 4×
“A direct role of CD4 1 CD28 null T cells in vascular injury has been suggested because these cells are also a risk factor for inflammation and rupturing of atherosclerotic plaques in acute coronary syndromes (13, 14).”
BackgroundInfluentialSelf-citationVales-Gomez, M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.15.4250 · Cited by 384
Biassoni, R., Cantoni, C., Falco, M., Verdiani, S., Bottino, C., Vitale, M., Conte, R., Poggi, A., Moretta, A., & Moretta, L. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.2.645 · Cited by 342
Wagtmann, N., Rajagopalan, S., Winter, C. C., Peruui, M., & Long, E. O. (1995) · Immunity · doi:10.1016/1074-7613(95)90069-1 · Cited by 335
Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes
D'Andrea, A., Chang, C., Franz-Bacon, K., McClanahan, T., Phillips, J. H., & Lanier, L. L. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.5.2306 · Cited by 310
Expansion of unusual CD4+ T cells in severe rheumatoid arthritis
Martens, P. B., Goronzy, J. J., Schaid, D., & Weyand, C. M. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400615 · Cited by 290
Self-citationWeyand, C. M., Xie, C., & Goronzy, J. J. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115814 · Cited by 228
Self-citationFunctional subsets of CD4 T cells in rheumatoid synovitis
Namekawa, T., Wagner, U. G., Goronzy, J. J., & Weyand, C. M. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199812)41:12<2108::aid-art5>3.0.co;2-q · Cited by 220
Self-citationDAP12-mediated Signal Transduction in Natural Killer Cells
McVicar, D. W., Taylor, L. S., Gosselin, P., Willette-Brown, J., Mikhael, A. I., Geahlen, R. L., Nakamura, M. C., Linnemeyer, P., Seaman, W. E., Anderson, S. K., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32934 · Cited by 211
Namekawa, T., Snyder, M. R., Yen, J.-H., Goehring, B. E., Leibson, P. J., Weyand, C. M., & Goronzy, J. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.2.1138 · Cited by 210
Self-citationFunctional properties of CD4+CD28− T cells in the aging immune system
Weyand, C. M., Brandes, J. C., Schmidt, D., Fulbright, J. W., & Goronzy, J. J. (1998) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(97)00161-9 · Cited by 199
Self-citationHLA heterozygosity contributes to susceptibility to rheumatoid arthritis
(2001) · Classic Papers in Rheumatology · doi:10.3109/9780203214237-44 · Cited by 193
Follow the leader: NK cell receptors for classical and nonclassical MHC class I.
Lanier, L. (1998) · Cell · doi:10.1016/s0092-8674(00)81398-7 · Cited by 181
Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptors
Valés-Gómez, M., Reyburn, H. T., Erskine, R. A., & Strominger, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14326 · Cited by 175
Colonna, M., Spies, T. A., Strominger, J. L., Ciccone, E., Moretta, A., Moretta, L., Pende, D., & Viale, O. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.17.7983 · Cited by 170
The influence of sex on the phenotype of rheumatoid arthritis
Weyand, C. M., Schmidt, D., Wagner, U. G., & Goronzy, J. J. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199805)41:5<817::aid-art7>3.0.co;2-s · Cited by 165
Self-citationMoosig, F., Csernok, E., Wang, G., & Gross, W. L. (1998) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1998.00695.x · Cited by 138
Peptide sequence requirements for the recognition of HLA-B*2705 by specific natural killer cells
Peruzzi, M., Parker, K. C., Long, E. O., & Malnati, M. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.8.3350 · Cited by 137
PATHOGENESIS OF RHEUMATOID ARTHRITIS
Weyand, C. M., & Goronzy, J. J. (1997) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70504-6 · Cited by 127
Self-citationHeterogeneity of rheumatoid arthritis: from phenotypes to genotypes
Weyand, C. M., Klimiuk, P. A., & Goronzy, J. J. (1998) · Springer Seminars in Immunopathology · doi:10.1007/bf00831996 · Cited by 125
Self-citationMajor Histocompatibility Complex-Directed Susceptibility to Rheumatoid Arthritis
Nepom, G. T. (1998) · Advances in immunology · doi:10.1016/s0065-2776(08)60563-5 · Cited by 104
Self and viral peptides can initiate lysis by autologous natural killer cells.
Mandelboim, O., Wilson, S., Valés-Gómez, M., Reyburn, H., & Strominger, J. (1997) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.94.9.4604 · Cited by 89
PLAQUE DISRUPTION AND THROMBOSIS
Shah, P. K. (1999) · Cardiology Clinics · doi:10.1016/s0733-8651(05)70074-6 · Cited by 82
Mandelboim, O., Kent, S. C., Davis, D. M., Wilson, S. B., Okazaki, T., Jackson, R. A., Hafler, D. A., & Strominger, J. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3798 · Cited by 75
Selvakumar, A., Staffens, U., Palanisamy, N., Chaganti, R. S. K., & Dupont, B. (1997) · Tissue Antigens · doi:10.1111/j.1399-0039.1997.tb02803.x · Cited by 69
The Germline and Somatic Genetic Basis for Rheumatoid Arthritis
Ollier, W., & WINCHESTER, R. J. (1999) · KARGER eBooks · doi:10.1159/000060486 · Cited by 14
Potential Role of Inflammation and Infection
Shah, P. K. (1999) · Cited by 10
Susceptibility Genes in Rheumatoid Arthritis
Corn�lis, F. (2000) · KARGER eBooks · doi:10.1159/000060511 · Cited by 7
Cited by
Lanier, L. L. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115526 · Cited by 2,769
MHC class I molecules and kirs in human history, health and survival
Parham, P. (2005) · Nature Reviews Immunology · doi:10.1038/nri1570 · Cited by 1,203
HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection
Khakoo, S. I., Thio, C. L., Martin, M. P., Brooks, C. R., Gao, X., Astemborski, J., Cheng, J., Goedert, J. J., Vlahov, D., Hilgartner, M., et al. (2004) · Science · doi:10.1126/science.1097670 · Cited by 1,179
Hiby, S. E., Walker, J. J., O'Shaughnessy, K. M., Redman, C. W. G., Carrington, M., Trowsdale, J., & Moffett, A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041214 · Cited by 1,121
KIR: Diverse, Rapidly Evolving Receptors of Innate and Adaptive Immunity
Vilches, C., & Parham, P. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.092501.134942 · Cited by 986
Metadata
- Authors
- Yen, J.-H., Moore, B. E., Nakajima, T., Scholl, D., Schaid, D. J., Weyand, C. M., & Goronzy, J. J.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2001-05-14
- Volume
- 193
- Issue
- 10
- Pages
- 1159-1168
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2164224372
- Cited by
- 335
- References
- 43
- FWCI
- 13.47
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.